Richard D. Schulick

56.7k total citations · 9 hit papers
347 papers, 32.7k citations indexed

About

Richard D. Schulick is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard D. Schulick has authored 347 papers receiving a total of 32.7k indexed citations (citations by other indexed papers that have themselves been cited), including 241 papers in Oncology, 165 papers in Surgery and 91 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard D. Schulick's work include Pancreatic and Hepatic Oncology Research (188 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (73 papers) and Neuroendocrine Tumor Research Advances (61 papers). Richard D. Schulick is often cited by papers focused on Pancreatic and Hepatic Oncology Research (188 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (73 papers) and Neuroendocrine Tumor Research Advances (61 papers). Richard D. Schulick collaborates with scholars based in United States, Japan and Italy. Richard D. Schulick's co-authors include John L. Cameron, Michael A. Choti, Christopher L. Wolfgang, Barish H. Edil, Ralph H. Hruban, Jean‐Nicolas Vauthey, Timothy M. Pawlik, Ksenija Slankamenac, Rolf Graf and René Vonlanthen and has published in prestigious journals such as Science, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Richard D. Schulick

330 papers receiving 32.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Clavien-Dindo Classification of Surgical Complications

2009 8.4k citations Richard D. Schulick et al. profile →
DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

2011 1.2k citations Yuchen Jiao, Chanjuan Shi et al. Science profile →
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience

2006 1.2k citations Ralph H. Hruban, Richard D. Schulick et al. profile →
Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases

2002 1.1k citations Michael A. Choti, Richard D. Schulick et al. profile →
Cholangiocarcinoma

2007 970 citations Michael A. Choti, Richard D. Schulick et al. profile →
Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis

2009 578 citations Richard D. Schulick, Michael A. Choti et al. profile →
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

2011 562 citations Jian Wu, Hanno Matthaei et al. Science Translational Medicine profile →
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors

2012 380 citations Roeland F. de Wilde, Anirban Maitra et al. profile →
Laparoscopic Distal Pancreatectomy Is Associated With Significantly Less Overall Morbidity Compared to the Open Technique

2012 374 citations Barish H. Edil, Richard D. Schulick et al. profile →

Peers

Countries citing papers authored by Richard D. Schulick

Since Specialization

Citations

This map shows the geographic impact of Richard D. Schulick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Schulick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Schulick more than expected).

Fields of papers citing papers by Richard D. Schulick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Schulick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Schulick. The network helps show where Richard D. Schulick may publish in the future.

Co-authorship network of co-authors of Richard D. Schulick

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Schulick. A scholar is included among the top collaborators of Richard D. Schulick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Schulick. Richard D. Schulick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frozen section pathology in IPMN : A systematic review 2025 ·Journal of Hepato-Biliary-Pancreatic Sciences ·Michael J. Kirsch, Salvador Rodriguez Franco, (unknown), Oskar Franklin, Richard D. Schulick, Marco Del Chiaro	1
2	The Shifting Target: Redefining Timing and Risk in the Management of Mucinous Pancreatic Cysts 2025 ·Journal of Hepato-Biliary-Pancreatic Sciences ·(unknown), Hiroyuki Ishida, Richard D. Schulick, Marco Del Chiaro	0
3	Enhancing the National Cancer Database content using natural language processing and electronic health record data 2024 ·Christina M. Stuart, (unknown), Richard D. Schulick, Kathryn Colborn, Robert A. Meguid	0
4	Pathological Features Associated with Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors 2024 ·Cancers ·Salvador Rodriguez Franco, (unknown), Ying Jin, (unknown), (unknown), (unknown), (unknown), Oskar Franklin, Alexis D. Leal, Christopher H. Lieu, Richard D. Schulick, Marco Del Chiaro, Steven A. Ahrendt, Martin D. McCarter, Ana Gleisner	0
5	Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database 2024 ·Pancreatology ·Toshitaka Sugawara, Salvador Rodriguez Franco, (unknown), Michael J. Kirsch, Kathryn Colborn, Oskar Franklin, Jun Ishida, (unknown), Mohammed Al-Musawi, Ana Gleisner, Richard D. Schulick, Marco Del Chiaro	1
6	The association between social vulnerability and oncologic stage and treatment in the United States 2024 ·Christina M. Stuart, Adam R. Dyas, Michael R. Bronsert, Catherine G. Velopulos, William G. Henderson, Richard D. Schulick, Robert A. Meguid	2
7	Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis 2023 ·Cancers ·Ioannis A. Ziogas, Salvador Rodriguez Franco, (unknown), Cheryl Meguid, (unknown), Mohammed Al-Musawi, Sophoclis P. Alexopoulos, Richard D. Schulick, Marco Del Chiaro	13
8	Prevalence and progression of intraductal papillary mucinous neoplasms of the pancreas in solid organ transplant recipients: A systematic review 2023 ·American Journal of Transplantation ·Toshitaka Sugawara, Salvador Rodriguez Franco, Jun Ishida, Avash Kalra, Jessica L. Saben, (unknown), Michael J. Kirsch, Mohammed Al-Musawi, Bruce Kaplan, Elizabeth A. Pomfret, Richard D. Schulick, Marco Del Chiaro	4
9	Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases 2021 ·Cancers ·Yan‐Dong Wu, Atsushi Oba, Laurel Beaty, Kathryn Colborn, Salvador Rodriguez Franco, Ben Harnke, Cheryl Meguid, (unknown), Roberto Valente, Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro	11
10	Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity 2018 ·Cancer Research ·Yuki Fujiwara, Yi Sun, Robert J. Torphy, (unknown), Katsuhiko Yanaga, Barish H. Edil, Richard D. Schulick, Yuwen Zhu	22
11	Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity‐modulated radiation therapy (IMRT) in pancreatic adenocarcinoma 2018 ·Journal of Surgical Oncology ·Brandon C. Chapman, Ana Gleisner, (unknown), Cheryl Meguid, Karyn A. Goodman, Brian Brauer, Csaba Gajdos, Richard D. Schulick, Barish H. Edil, Martin D. McCarter	15
12	Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature 2017 ·Alessandro Paniccia, Robert J. Torphy, Kalpana Devaraj, Richard D. Schulick	0
13	Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature 2017 ·SHILAP Revista de lepidopterología ·Alessandro Paniccia, Robert J. Torphy, Kalpana Devaraj, Richard D. Schulick	3
14	Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer 2017 ·Journal of Surgical Oncology ·Brandon C. Chapman, Patrick Hosokawa, William G. Henderson, Alessandro Paniccia, Douglas M. Overbey, Wells A. Messersmith, Christopher H. Lieu, Greg V. Stiegmann, Richard D. Schulick, Csaba Gajdos	9
15	miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts 2012 ·Clinical Cancer Research ·Hanno Matthaei, Dennis Wylie, (unknown), Marco Dal Molin, Jon Kemppainen, Skye C. Mayo, Christopher L. Wolfgang, Richard D. Schulick, (unknown), Bernard F. Andruss, Alex Adai, Ralph H. Hruban, Anna E. Szafranska-Schwarzbach, Anirban Maitra	126
16	DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors breakdown → 2011 ·Science ·Yuchen Jiao, Chanjuan Shi, Barish H. Edil, Roeland F. de Wilde, David S. Klimstra, Anirban Maitra, Richard D. Schulick, Laura H. Tang, Christopher L. Wolfgang, Michael A. Choti, Victor E. Velculescu, Luis A. Díaz, Bert Vogelstein, Kenneth W. Kinzler, Ralph H. Hruban, Nickolas Papadopoulos	1244
17	Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development breakdown → 2011 ·Science Translational Medicine ·Jian Wu, Hanno Matthaei, Anirban Maitra, Marco Dal Molin, Laura D. Wood, James R. Eshleman, Michael Goggins, Marcia Irene Canto, Richard D. Schulick, Barish H. Edil, Christopher L. Wolfgang, Alison P. Klein, Luis A. Díaz, Peter J. Allen, C. Max Schmidt, Kenneth W. Kinzler, Nickolas Papadopoulos, Ralph H. Hruban, Bert Vogelstein	562
18	Integrin α2 Mediates Selective Metastasis to the Liver 2009 ·Cancer Research ·Kiyoshi Yoshimura, Kristen F. Meckel, (unknown), Christina Y. Chia, Jang‐June Park, Kelly Olino, Ryouichi Tsunedomi, Toshio HARADA, Norio Iizuka, Shoichi Hazama, Yukihiko Kato, Jesse W. Keller, John M. Thompson, Fumin Chang, Lewis H. Romer, Ajay Jain, Christine A. Iacobuzio–Donahue, Masaaki Oka, Drew M. Pardoll, Richard D. Schulick	69
19	Live Attenuated Listeria Monocytogenes Effectively Treats Hepatic Colorectal Cancer Metastases and Is Strongly Enhanced by Depletion of Regulatory T Cells 2007 ·Cancer Research ·Kiyoshi Yoshimura, (unknown), Christina Y. Chia, Kristen F. Meckel, Jill E. Slansky, John M. Thompson, Ajay Jain, Drew M. Pardoll, Richard D. Schulick	29
20	Selective Targeting of Antitumor Immune Responses with Engineered Live-Attenuated Listeria monocytogenes 2006 ·Cancer Research ·Kiyoshi Yoshimura, Ajay Jain, Heather E. Allen, (unknown), Christina Y. Chia, Sowmya Ravi, Dirk G. Brockstedt, Martin Giedlin, Keith S. Bahjat, Meredith L. Leong, Jill E. Slansky, David N. Cook, Thomas W. Dubensky, Drew M. Pardoll, Richard D. Schulick	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact